List of Tables
    Table 1. Kinetosis Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Kinetosis Drugs Market Trends
    Table 3. Kinetosis Drugs Market Drivers
    Table 4. Kinetosis Drugs Market Challenges
    Table 5. Kinetosis Drugs Market Restraints
    Table 6. Global Kinetosis Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Kinetosis Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Kinetosis Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Kinetosis Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Kinetosis Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Kinetosis Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Kinetosis Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Kinetosis Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Kinetosis Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Kinetosis Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Kinetosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Kinetosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinetosis Drugs as of 2021)
    Table 18. Top Players of Kinetosis Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Kinetosis Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Kinetosis Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Kinetosis Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Kinetosis Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Kinetosis Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Kinetosis Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Kinetosis Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Kinetosis Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Kinetosis Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Kinetosis Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Kinetosis Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Kinetosis Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Kinetosis Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Kinetosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Kinetosis Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Kinetosis Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Kinetosis Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Kinetosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Kinetosis Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Kinetosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Kinetosis Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Kinetosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GlaxoSmithKline Corporation Information
    Table 43. GlaxoSmithKline Description and Business Overview
    Table 44. GlaxoSmithKline Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. GlaxoSmithKline Kinetosis Drugs Product
    Table 46. GlaxoSmithKline Recent Development
    Table 47. Prestige Brands Corporation Information
    Table 48. Prestige Brands Description and Business Overview
    Table 49. Prestige Brands Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Prestige Brands Product
    Table 51. Prestige Brands Recent Development
    Table 52. WellSpring Pharmaceutical Corporation Corporation Information
    Table 53. WellSpring Pharmaceutical Corporation Description and Business Overview
    Table 54. WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. WellSpring Pharmaceutical Corporation Product
    Table 56. WellSpring Pharmaceutical Corporation Recent Development
    Table 57. Baxter International Corporation Information
    Table 58. Baxter International Description and Business Overview
    Table 59. Baxter International Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Baxter International Product
    Table 61. Baxter International Recent Development
    Table 62. Mylan Corporation Information
    Table 63. Mylan Description and Business Overview
    Table 64. Mylan Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Mylan Product
    Table 66. Mylan Recent Development
    Table 67. Sandoz Corporation Information
    Table 68. Sandoz Description and Business Overview
    Table 69. Sandoz Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Sandoz Product
    Table 71. Sandoz Recent Development
    Table 72. Pfizer Corporation Information
    Table 73. Pfizer Description and Business Overview
    Table 74. Pfizer Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Pfizer Product
    Table 76. Pfizer Recent Development
    Table 77. Myungmoon Pharm Corporation Information
    Table 78. Myungmoon Pharm Description and Business Overview
    Table 79. Myungmoon Pharm Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Myungmoon Pharm Product
    Table 81. Myungmoon Pharm Recent Development
    Table 82. Caleb Pharmaceuticals Corporation Information
    Table 83. Caleb Pharmaceuticals Description and Business Overview
    Table 84. Caleb Pharmaceuticals Kinetosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Caleb Pharmaceuticals Product
    Table 86. Caleb Pharmaceuticals Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Kinetosis Drugs Customers List
    Table 90. Kinetosis Drugs Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Kinetosis Drugs Product Picture
    Figure 2. Global Kinetosis Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Kinetosis Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Kinetosis Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Kinetosis Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Kinetosis Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Kinetosis Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Kinetosis Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Kinetosis Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Kinetosis Drugs Report Years Considered
    Figure 11. Product Picture of Anticholinergic
    Figure 12. Product Picture of Antihistamines
    Figure 13. Product Picture of Others
    Figure 14. Global Kinetosis Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Kinetosis Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Kinetosis Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Kinetosis Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Kinetosis Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Kinetosis Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Kinetosis Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Kinetosis Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Kinetosis Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Kinetosis Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Kinetosis Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Kinetosis Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Adults
    Figure 27. Product Picture of Children
    Figure 28. Global Kinetosis Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Kinetosis Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Kinetosis Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Kinetosis Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Kinetosis Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Kinetosis Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Kinetosis Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Kinetosis Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Kinetosis Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Kinetosis Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Kinetosis Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Kinetosis Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Kinetosis Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Kinetosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Kinetosis Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Kinetosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Kinetosis Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Kinetosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Kinetosis Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Kinetosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Kinetosis Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Kinetosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Kinetosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Kinetosis Drugs Value Chain
    Figure 74. Kinetosis Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed